Neuroimaging Predictors of Improvement to Pivotal Response Treatment (PRT) in Young Children With Autism
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 36
- 试验地点
- 2
- 主要终点
- Change in Number of Child Utterances During a Structured Lab Observation (SLO)
研究概览
简要总结
Autism spectrum disorder (ASD) is a very heterogeneous disorder with limited empirically validated behavioral and biological interventions. The goal of this pilot investigation is to apply a biologically-based approach to identify predictors of treatment response in children with ASD who are receiving Pivotal Response Treatment (PRT), an evidence-based behavioral intervention. Specifically, the investigators propose to identify neuroimaging biomarkers of treatment response to a PRT program (PRT-P) targeting language deficits in young children with ASD who will be randomized to either PRT-P or to a delayed treatment group (DTG).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 2 Years 至 4 Years(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of Autism Spectrum Spectrum Disorder (ASD) based on clinical interview and Diagnostic and Statistical Manual, 5th edition (DSM-5) and confirmed using the Autism Diagnostic Interview Revised (ADI-R) and the Autism Diagnostic Observation Schedule (ADOS) and/or Brief Observation of Symptoms of Autism (BOSA) and/or Childhood Autism Rating Scale- Second Edition (CARS-2).
- •Outpatients between 2.0 and 4.11 years of age of either gender,
- •Children of all cognitive levels will be included as long as they are able to participate in the testing procedures to the extent that valid standard scores can be obtained
- •Language delay as measured by the Preschool Language Scale, 5th Edition (PLS-5) [at least 1 standard deviation behind for children age 2 and 3 years; and 2 standard deviations behind for children age 4],
- •Stable psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation,
- •Stable treatment [Applied Behavior Analysis (ABA), Floortime, or other interventions], speech therapy, and school placement for at least 1 month prior to baseline measurements with no expected changes during study participation,
- •No more than 60 minutes of 1:1 speech therapy per week,
- •The child's exposure to the English language must be sufficient that administration of standardized tests in English is appropriate for measuring progress,
- •The availability of at least one parent who can consistently participate in the training sessions and related activities, and
- •Successful completion of baseline brain scan.
排除标准
- •Current or life-time diagnosis of severe psychiatric disorder (e.g., bipolar disorder),
- •Genetic abnormality (e.g., Fragile X)
- •Presence of active medical problem (e.g., unstable seizure disorder),
- •Receiving more than 15 hours of in home 1:1 Applied Behavior Analysis (ABA) per week
- •Magnetic Resonance (MR) contraindication (e.g., the presence of ferrous metal), or
- •Previous adequate Pivotal Response Treatment (PRT) trial.
结局指标
主要结局
Change in Number of Child Utterances During a Structured Lab Observation (SLO)
时间窗: Baseline, 16 Weeks
次要结局
- Change on MacArthur-Bates Communication Development Inventory (CDI)(Baseline, 16 Weeks)
研究者
Antonio Hardan
Principal Investigator
Stanford University
